Books > Medicine > Surgery > Orthopaedics & fractures
|
Not currently available
Osteosarcoma (Hardcover, 1st ed. 2016)
Loot Price: R3,625
Discovery Miles 36 250
|
|
Osteosarcoma (Hardcover, 1st ed. 2016)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
This book reviews the brilliant progress made in the past three
decades in clinical outcomes for osteosarcoma patients treated with
a multidisciplinary approach, including limb-salvage surgery
combined with neoadjuvant multidrug chemotherapy and aggressive
management of pulmonary metastasis. Osteosarcoma was a miserable
disease for adolescents and young adults until the early 1970s,
with a survival rate that was less than 10-15% even after
amputation for affected limbs because of the progression of
pulmonary metastasis. With the development of neoadjuvant
chemotherapy for osteosarcoma, including high-dose methotrexate,
doxorubicin, cisplatin, and ifosfamide during the late 1970s and
the 1980s, however, the prognosis has dramatically improved.
Limb-salvage surgery for patients with extremity osteosarcoma is
now a gold-standard surgical procedure for more than 90% of
patients with localized disease. Additionally, aggressive pulmonary
metastasectomy for patients with lung metastasis from osteosarcoma
has contributed to improvement of their survival. More recently,
carbon-ion radiotherapy has also been introduced for patients with
unresectable osteosarcoma of the trunk, as in the spine and pelvis.
In this volume the author provides valuable descriptions of an
important new treatment modality for a multidisciplinary approach
for osteosarcoma patients.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.